PNC Financial Services Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Buy |
1,185
+1,047
| +759% | +$16.8K | ﹤0.01% | 3598 |
|
|
2025
Q1 | $2.36K | Buy |
138
+59
| +75% | +$1.01K | ﹤0.01% | 4297 |
|
|
2024
Q4 | $1.96K | Buy |
79
+24
| +44% | +$594 | ﹤0.01% | 4288 |
|
|
2024
Q3 | $1.57K | Sell |
55
-110
| -67% | -$3.14K | ﹤0.01% | 4336 |
|
|
2024
Q2 | $4.36K | Sell |
165
-30
| -15% | -$792 | ﹤0.01% | 4032 |
|
|
2024
Q1 | $6.3K | Sell |
195
-22
| -10% | -$711 | ﹤0.01% | 3893 |
|
|
2023
Q4 | $9.14K | Sell |
217
-71
| -25% | -$2.99K | ﹤0.01% | 3757 |
|
|
2023
Q3 | $11.1K | Buy |
+288
| New | +$11.1K | ﹤0.01% | 3710 |
|
|
2023
Q1 | – | Sell |
-45,601
| Closed | -$809K | – | 4754 |
|
|
2022
Q4 | $809K | Hold |
45,601
| – | – | ﹤0.01% | 1242 |
|
|
2022
Q3 | $254K | Hold |
45,601
| – | – | ﹤0.01% | 1934 |
|
|
2022
Q2 | $178K | Sell |
45,601
-131
| -0.3% | -$511 | ﹤0.01% | 2226 |
|
|
2022
Q1 | $252K | Sell |
45,732
-402
| -0.9% | -$2.22K | ﹤0.01% | 2109 |
|
|
2021
Q4 | $393K | Buy |
46,134
+10,389
| +29% | +$88.5K | ﹤0.01% | 1854 |
|
|
2021
Q3 | $311K | Buy |
+35,745
| New | +$311K | ﹤0.01% | 1919 |
|